journal article·2023-11-01Open access

Superhydrophobic Tipped Antimicrobial Photodynamic Therapy Device for the In Vivo Treatment of Periodontitis Using a Wistar Rat Model

Caroline Coradi Tonon, Alessandra Nara de Souza Rastelli, Chathuna Bodahandi, Goutam Ghosh, Tayyaba Hasan, QianFeng Xu, Alexander Greer, Alan M. Lyons

ACS Applied Materials & Interfaces· Volume 15· Issue 43

Abstract

Limited options exist for treatment of periodontitis; scaling and root planing (SRP) are not sufficient to eradicate P. gingivalis and the resulting inflammatory disease. Chlorhexidine (CHX), used as an adjuvant to SRP, may reduce bacterial loads but leads to pain and staining, while evidence for its efficacy is lacking. Antibiotics are effective but can lead to drug-resistance. The rising concern of antibiotic resistance limits the future use of this treatment approach. This study evaluates the efficacy of a novel superhydrophobic (SH) antimicrobial photodynamic therapy (aPDT) device as an adjuvant to SRP for the treatment of periodontitis induced in a Wistar rat in vivo model relative to CHX. The SH-aPDT device comprises an SH silicone rubber strip coated with verteporfin photosensitizer (PS), sterilized, and secured onto a tapered plastic optical fiber tip connected to a red diode laser. The superhydrophobic polydimethylsiloxane (PDMS) strips were fabricated by using a novel soluble template method that creates a medical-grade elastomer with hierarchical surface roughness without the use of nanoparticles. Superhydrophobicity minimizes direct contact of the PS-coated surface with bacterial biofilms. Upon insertion of the device tip into the pocket and energizing the laser, the device generates singlet oxygen that effectively targets and eliminates bacteria within the periodontal pocket. SH-aPDT treatment using 125 J/cm 2 of red light on three consecutive days reduced P. gingivalis significantly more than SRP-CHX controls ( p < 0.05). Clinical parameters significantly improved ( p < 0.05), and histology and stereometry results demonstrated SH-aPDT to be the most effective treatment for improving healing and reducing inflammation, with an increase in fibroblast cells and extracellular matrix and a reduction in vascularization, inflammatory cells, and COX-2 expression. The SH-aPDT approach resulted in complete disease clearance assessed 30 days after treatment initiation with significant reduction of the periodontal pocket and re-formation of the junctional epithelium at the enamel–cementum junction. PS isolation on a SH strip minimizes the potential for bacteria to develop resistance, where the treatment may be aided by the oxygen supply retained within the SH surface.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Ocular Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, 40 Blossom Street, Boston, Massachusetts 02114, United States

Department of Restorative Dentistry, School of Dentistry, Araraquara, Sao Paulo State University─UNESP, 1680 Humaita Street, Araraquara, SP 14801-903, Brazil

Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, 365 Fifth Avenue, New York, New York 10016, United States

Department of Chemistry, College of Staten Island, City University of New York, Staten Island, New York 10314, United States

SingletO2 Therapeutics LLC, VentureLink, Room 524B, 211 Warren Street, Newark, New Jersey 07103, United States

Division of Health Sciences and Technology, Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Department of Chemistry, Brooklyn College, City University of New York, Brooklyn, New York 11210, United States

Funding

National Institute of Dental and Craniofacial Research

References (73)

Show source-provided references
1. 10.1590/S1806-8324201200070000710.1590/S1806-83242012000700007 ↗
2. 10.1902/jop.1998.69.9.103610.1902/jop.1998.69.9.1036 ↗
3. 10.1902/jop.2016.16021410.1902/jop.2016.160214 ↗
4. 10.1902/jop.2016.16026810.1902/jop.2016.160268 ↗
5. 10.1016/j.pdpdt.2017.05.00710.1016/j.pdpdt.2017.05.007 ↗
6. 10.1590/1807-3107bor-2017.vol31.006710.1590/1807-3107bor-2017.vol31.0067 ↗
7. 10.1002/14651858.CD004622.pub310.1002/14651858.CD004622.pub3 ↗
8. 10.1002/14651858.CD008676.pub210.1002/14651858.CD008676.pub2 ↗
9. 10.3389/fmicb.2019.0058710.3389/fmicb.2019.00587 ↗
10. 10.1016/j.pdpdt.2015.06.01010.1016/j.pdpdt.2015.06.010 ↗
11. 10.3390/biom704007910.3390/biom7040079 ↗
12. 10.1016/j.nmni.2015.02.00710.1016/j.nmni.2015.02.007 ↗
13. 10.1016/j.tiv.2007.09.01210.1016/j.tiv.2007.09.012 ↗
14. 10.3390/app1110462910.3390/app11104629 ↗
15. 10.1002/lsm.2036110.1002/lsm.20361 ↗
16. 10.1093/jac/42.1.1310.1093/jac/42.1.13 ↗
17. 10.1111/j.1600-0757.2010.00346.x10.1111/j.1600-0757.2010.00346.x ↗
18. 10.1021/ar050191g10.1021/ar050191g ↗
19. 10.1111/php.1271610.1111/php.12716 ↗
20. 10.1111/php.1347010.1111/php.13470 ↗
21. 10.1111/php.1377410.1111/php.13774 ↗
22. 10.1007/s10103-019-02733-410.1007/s10103-019-02733-4 ↗
23. 10.1016/j.pdpdt.2019.10159110.1016/j.pdpdt.2019.101591 ↗
24. 10.1590/1678-77572013003810.1590/1678-775720130038 ↗
25. 10.1902/jop.2008.08010310.1902/jop.2008.080103 ↗
26. 10.1016/j.pdpdt.2018.11.00310.1016/j.pdpdt.2018.11.003 ↗
27. 10.1111/j.1600-051X.2011.01785.x10.1111/j.1600-051X.2011.01785.x ↗
28. 10.1007/s10103-015-1820-810.1007/s10103-015-1820-8 ↗
29. 10.1089/pho.2010.296910.1089/pho.2010.2969 ↗
30. 10.1016/j.pdpdt.2017.03.00810.1016/j.pdpdt.2017.03.008 ↗
31. 10.1016/j.jphotobiol.2017.06.03910.1016/j.jphotobiol.2017.06.039 ↗
32. 10.1038/s41598-019-44498-410.1038/s41598-019-44498-4 ↗
33. 10.1007/s10103-016-1960-510.1007/s10103-016-1960-5 ↗
34. 10.1016/j.jphotobiol.2017.08.01210.1016/j.jphotobiol.2017.08.012 ↗
35. 10.1089/pho.2016.410210.1089/pho.2016.4102 ↗
36. 10.1128/AAC.47.3.932-940.200310.1128/AAC.47.3.932-940.2003 ↗
37. 10.1073/pnas.061132810410.1073/pnas.0611328104 ↗
38. 10.1111/jcpe.1323610.1111/jcpe.13236 ↗
39. 10.1002/JPER.18-037310.1002/JPER.18-0373 ↗
40. 10.1089/pho.2010.292210.1089/pho.2010.2922 ↗
41. 10.1016/j.jphotobiol.2016.04.01910.1016/j.jphotobiol.2016.04.019 ↗
42. 10.1016/j.pdpdt.2017.10.02410.1016/j.pdpdt.2017.10.024 ↗
43. 10.1021/jm401949210.1021/jm4019492 ↗
44. 10.1111/php.1346110.1111/php.13461 ↗
45. 10.1002/cptc.20180006210.1002/cptc.201800062 ↗
46. 10.1021/es071762y10.1021/es071762y ↗
47. 10.1016/j.apcatb.2006.05.01510.1016/j.apcatb.2006.05.015 ↗
48. 10.1039/C5RA09045H10.1039/C5RA09045H ↗
49. 10.1016/j.jcat.2008.04.00110.1016/j.jcat.2008.04.001 ↗
50. 10.1002/adsc.20030318110.1002/adsc.200303181 ↗
51. 10.1039/C9PY00157C10.1039/C9PY00157C ↗
52. 10.1021/acsami.1c0286310.1021/acsami.1c02863 ↗
53. 10.1021/acs.chemrev.5b0070710.1021/acs.chemrev.5b00707 ↗
54. 10.1021/acsanm.1c0143610.1021/acsanm.1c01436 ↗
55. 10.1021/ol302342410.1021/ol3023424 ↗
56. 10.1039/c0sc00641f10.1039/c0sc00641f ↗
57. 10.1021/acsami.7b1327310.1021/acsami.7b13273 ↗
58. 10.1016/j.jphotobiol.2022.11245810.1016/j.jphotobiol.2022.112458 ↗
59. 10.1021/acsami.8b0943910.1021/acsami.8b09439 ↗
60. 10.1021/ja410529q10.1021/ja410529q ↗
61. 10.1021/jp503149x10.1021/jp503149x ↗
62. Lyons, A. M.; Greer, A.; Xu, Q. F. Singlet Oxygen Generating Device for Selective Destruction of Pathogens. U.S. Non-Provisional Application 20210138258, filed May 13, 2021.
63. 10.1021/am507631510.1021/am5076315 ↗
64. 10.1021/la201222a10.1021/la201222a ↗
65. 10.1016/S0039-6257(00)00158-210.1016/S0039-6257(00)00158-2 ↗
66. Tonon, C. C.; Xu, Q. F.; Nara de Sousa Rastelli, A.; Ghosh, G.; Hasan, T.; Greer, A.; Lyons, A. M. Manuscript in preparation.
67. 10.1902/jop.1996.67.6.55510.1902/jop.1996.67.6.555 ↗
68. 10.3109/0001635630901124010.3109/00016356309011240 ↗
69. 10.1111/jcpe.1276810.1111/jcpe.12768 ↗
70. 10.1902/jop.1975.46.10.60310.1902/jop.1975.46.10.603 ↗
71. 10.1016/j.archoralbio.2011.03.02210.1016/j.archoralbio.2011.03.022 ↗
72. Visudyne (verteporfin), [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC. https://www.bauschretinarx.com/globalassets/pdf/packageinserts/pharma/visudyne-prescribing-information.pdf (accessed May 8, 2023).
73. 10.1016/j.pdpdt.2017.10.01510.1016/j.pdpdt.2017.10.015 ↗